Clinical trial registry record

Safety and Tolerability Study of Mesenchymal Stem Cells, HeXell-2020, in Elderly Subjects With Mild to Moderate Frailty Syndrome

A registered PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Not Yet Recruiting.
Evidence
Registered phase 1 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated September 4, 2025.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT07144072
Last registry update
September 4, 2025
Status
Not Yet Recruiting
Phase
Phase 1
Sponsor
Hexun Biosciences Co., LTD.
Enrollment
12
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 1
Study design
NA · SEQUENTIAL · TREATMENT · NONE
Evidence population
Human clinical study registration
Participants
12
Population
ALL · 60 Years to 85 Years
Duration
2026-01-31 to 2028-07-31
Intervention
HeXell-2020
Comparator
Not reported
Outcomes measured
Maximum Feasible Dose (MFD) determination — Within 14 days after completion of the last study treatment (day 28 for 3 d…; Incidence of Treatment-Emergent Adverse Events (TEAEs). — Within the first year after cell transplantation.; Incidence of withdrawals due to AEs — Within the first year after cell transplantation.; Mean change from baseline in exercise performance as measured by change in the six-minute walk test (6MWT) total distan…; Mean change from baseline in hand grip strength as measured by change in maximum force using hand dynamometer. — Day 0…; Mean change from baseline in physical activity as measured by change in the Short Physical Performance Battery (SPPB) a…; Mean change from baseline in Clinical Frailty Scale (CFS) score. — Day 0 (baseline), Week 6, 12, 24, 36, 52; Mean change from baseline in quality of life as measured by change in the Falls Efficacy Scale- International (FES-I) q…; Mean change from baseline in quality of life as measured by change in the Patient-Reported Outcomes Measurement Informa…; Mean change from baseline in quality of life as measured by change in the 36-Item Short Form survey (SF-36) score. — Da…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 1A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Frailty · 100%Title contains controlled term: frailty. Abstract contains controlled term: frailty. Source terminology contains: frailty. Title supplies longevity context: frailty, frail. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

frailty
Open primary sourceExport JSON